Clinical Trial Update: Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating molecular imaging of myocardial fibrosis in cardiac amyloidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Cardiac Amyloidosis | Phase 3 | Status: COMPLETED